journa.host is one of the many independent Mastodon servers you can use to participate in the fediverse.
The server for working journalists and news outlets on Mastodon. Home to active & retired journalists, media scholars, and a variety of news and journalism adjacent professionals. #Newstodon

Server stats:

268
active users

#rsv

42 posts11 participants1 post today
Continued thread

Zuletzt gab es auch Rückschläge in der Gesundheitsforschung: Moderna hat seine mRNA-#Studie für einen #RSV-Impfstoff für Säuglinge gestoppt. Wie gefährlich ist das #Virus für Babys und welche Schutzmöglichkeiten gibt es zurzeit? #archiv #impfung riffreporter.de/de/wissen/rsv-

RiffReporter · mRNA-Impfstoff gegen das RS-Virus: Studienstopp bei SäuglingenBy Ulrike Gebhardt
Replied in thread

COVID numbers are going up, but #flu and #RSV cases continue to drop in #NYC. We still don't have accurate hospitalization numbers for #influenza and #RSVirus here, but it looks like the overall risk of hospitalization and death from acute airborne infectious diseases is dropping.

I'm going to plan for indoor dining and singing, and maybe travel, but as long as this many people are dying and being hospitalized I'll #WearAMask in elevators, trains, doctor's offices, pharmacies and supermarkets!

This article by Annette Regan, University of San Francisco, first appeared in The Conversation, republished with permission.

FDA’s approval of the world’s first vaccine against RSV will offer a new tool in an old fight – 4 questions answered cobbcountycourier.com/2023/05/

My toddler had a high fever and trouble breathing late last night and this morning. He's a bit better after a breathing treatment, and after all the news of kids needing to be hospitalized for RSV, I'm glad he didn't have to be admitted. But he is still miserable, and we aren't out of the woods yet. Please stay home if you are sick.

It went largely unnoticed, but GSK recently announced the results of a clinical trial showing its experimental RSV vaccine is 82.6% effective. It shares the same science as the COVID-19 vaccine and was crafted by the same NIH and academic scientists who created Moderna’s vaccine. But it took nearly a decade to get to Phase 3 trial, demonstrating the lack of urgency around most vaccine development.